Veru, Inc.

{
  "main_header": {
    "sid": 1162442,
    "name": "Veru, Inc.",
    "stock_name": "Veru, Inc.",
    "full_name": "Veru, Inc.",
    "name_url": "stocks-analysis/veru-inc",
    "exchange": 210,
    "exchangecode": "NAS",
    "country_id": 2,
    "currency": "USD",
    "cmp": "2.24",
    "chg": -0.32,
    "chgp": "-12.5%",
    "dir": -1,
    "prev_price": "2.56",
    "mcapval": "41.57",
    "mcap": "Micro Cap",
    "scripcode": "",
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 2305,
    "indexname": "S&P 500",
    "isin": "US92536C1036",
    "curr_date": "Feb 05",
    "curr_time": "",
    "bse_nse_vol": "58.73 k",
    "exc_status": "Active",
    "traded_date": "Feb 05, 2026",
    "traded_date_str": "2026 02 05",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/veru-inc-1162442-210&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Veru, Inc. Hits 52-Week Low at $2.11 Amid Market Volatility",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/veru-inc-hits-52-week-low-at-211-amid-market-volatility-3721497",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/VeruInc_priceRelatedfactors_3721497.png",
        "date": "2025-11-21 15:45:01",
        "description": "Veru, Inc. has reached a new 52-week low, reflecting ongoing challenges in the competitive Pharmaceuticals & Biotechnology sector. Despite a strong one-year performance, the company faces significant financial difficulties, including negative return on equity and a high price-to-book ratio, alongside declining operating profits and a modest market capitalization."
      },
      {
        "title": "Veru, Inc. Hits New 52-Week Low at $2.34 Amid Ongoing Challenges",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/veru-inc-hits-new-52-week-low-at-234-amid-ongoing-challenges-3718608",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/VeruInc_priceRelatedfactors_3718608.png",
        "date": "2025-11-20 16:26:19",
        "description": "Veru, Inc. has reached a new 52-week low, reflecting ongoing challenges despite a significant one-year performance increase. The company faces financial strain with negative return on equity and a declining operating profit. Its current market cap is USD 57 million, highlighting its microcap status in the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Veru, Inc. Hits 52-Week Low at $2.42 Amid Market Challenges",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/veru-inc-hits-52-week-low-at-242-amid-market-challenges-3686410",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/VeruInc_priceRelatedfactors_3686410.png",
        "date": "2025-11-10 17:04:59",
        "description": "Veru, Inc., a microcap in the Pharmaceuticals & Biotechnology sector, has hit a new 52-week low, reflecting ongoing market challenges despite a strong one-year performance. The company faces financial difficulties, including negative return on equity and a declining long-term growth outlook, necessitating a strategic reassessment."
      }
    ],
    "total": 12,
    "sid": "1162442",
    "stock_news_url": "https://www.marketsmojo.com/news/veru-inc-1162442"
  },
  "announcements": "",
  "corporate_actions": {
    "msg": "No corporate action Found"
  }
}

News and Views

Veru, Inc. Hits 52-Week Low at $2.11 Amid Market Volatility

2025-11-21 15:45:01

Veru, Inc. has reached a new 52-week low, reflecting ongoing challenges in the competitive Pharmaceuticals & Biotechnology sector. Despite a strong one-year performance, the company faces significant financial difficulties, including negative return on equity and a high price-to-book ratio, alongside declining operating profits and a modest market capitalization.

Read full news article

Veru, Inc. Hits New 52-Week Low at $2.34 Amid Ongoing Challenges

2025-11-20 16:26:19

Veru, Inc. has reached a new 52-week low, reflecting ongoing challenges despite a significant one-year performance increase. The company faces financial strain with negative return on equity and a declining operating profit. Its current market cap is USD 57 million, highlighting its microcap status in the Pharmaceuticals & Biotechnology sector.

Read full news article

Veru, Inc. Hits 52-Week Low at $2.42 Amid Market Challenges

2025-11-10 17:04:59

Veru, Inc., a microcap in the Pharmaceuticals & Biotechnology sector, has hit a new 52-week low, reflecting ongoing market challenges despite a strong one-year performance. The company faces financial difficulties, including negative return on equity and a declining long-term growth outlook, necessitating a strategic reassessment.

Read full news article

View All News